Skip to main content
. 2011 Aug 8;29(26):3529–3534. doi: 10.1200/JCO.2011.35.7806

Table 2.

Dose-Limiting Toxicity Summary (course 1)

MK-0752 mg/m2* No. of Patients Enrolled No. of Patients Evaluable No. of Patients With DLT DLT
200 3 3 0
260 6 6 2 Grade 3 AST (n = 2); grade 3 ALT (n = 2)
260 (expanded PK cohort) 14 12 1 Grade 3 ALT (n = 1)

Abbreviations: DLT, dose-limiting toxicity; PK, pharmacokinetics.

*

Dosage is expressed in mg/m2/dose administered 3 days on, 4 days off.

Both patients had both AST and ALT DLTs.